Publication Information

{'id': 'https://openalex.org/W2414183052', 'doi': 'https://doi.org/10.1358/dot.2015.51.11.2414528', 'title': 'Asunaprevir plus daclatasvir for the treatment of chronic hepatitis C virus infection', 'display_name': 'Asunaprevir plus daclatasvir for the treatment of chronic hepatitis C virus infection', 'publication_year': 2015, 'publication_date': '2015-01-01', 'ids': {'openalex': 'https://openalex.org/W2414183052', 'doi': 'https://doi.org/10.1358/dot.2015.51.11.2414528', 'mag': '2414183052', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/26744738'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1358/dot.2015.51.11.2414528', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S202615048', 'display_name': 'Drugs of today', 'issn_l': '1699-3993', 'issn': ['1699-3993', '1699-4019'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4360969288', 'host_organization_name': 'Prous Science', 'host_organization_lineage': ['https://openalex.org/P4360969288'], 'host_organization_lineage_names': ['Prous Science'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5087719632', 'display_name': 'J D Zeuli', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'J D Zeuli', 'raw_affiliation_strings': ['Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.', 'institution_ids': ['https://openalex.org/I1330342723']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5033714173', 'display_name': 'Sarah Adie', 'orcid': 'https://orcid.org/0000-0001-6218-2784'}, 'institutions': [{'id': 'https://openalex.org/I114493937', 'display_name': 'Creighton University', 'ror': 'https://ror.org/05wf30g94', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I114493937']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'S K Adie', 'raw_affiliation_strings': ['School of Pharmacy and Health Professions, Creighton University, Omaha, Nebraska, USA.'], 'affiliations': [{'raw_affiliation_string': 'School of Pharmacy and Health Professions, Creighton University, Omaha, Nebraska, USA.', 'institution_ids': ['https://openalex.org/I114493937']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5060574531', 'display_name': 'Stefano Rizza', 'orcid': 'https://orcid.org/0000-0001-5496-4890'}, 'institutions': [{'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'S A Rizza', 'raw_affiliation_strings': ['Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA.'], 'affiliations': [{'raw_affiliation_string': 'Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA.', 'institution_ids': ['https://openalex.org/I4210146710']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5048480083', 'display_name': 'Zelalem Temesgen', 'orcid': 'https://orcid.org/0000-0001-9179-6697'}, 'institutions': [{'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Z Temesgen', 'raw_affiliation_strings': ['Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA. [email protected].'], 'affiliations': [{'raw_affiliation_string': 'Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA. [email protected].', 'institution_ids': ['https://openalex.org/I4210146710']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.175, 'has_fulltext': False, 'cited_by_count': 6, 'citation_normalized_percentile': {'value': 0.221178, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 82, 'max': 83}, 'biblio': {'volume': '51', 'issue': '11', 'first_page': '629', 'last_page': '629'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10151', 'display_name': 'Hepatitis C virus research', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/2721', 'display_name': 'Hepatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10151', 'display_name': 'Hepatitis C virus research', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/2721', 'display_name': 'Hepatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.994, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11016', 'display_name': 'Monoclonal and Polyclonal Antibodies Research', 'score': 0.9801, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/daclatasvir', 'display_name': 'Daclatasvir', 'score': 0.99917006}, {'id': 'https://openalex.org/keywords/sofosbuvir', 'display_name': 'Sofosbuvir', 'score': 0.43568558}, {'id': 'https://openalex.org/keywords/ns3', 'display_name': 'NS3', 'score': 0.4218223}], 'concepts': [{'id': 'https://openalex.org/C2776979040', 'wikidata': 'https://www.wikidata.org/wiki/Q5207712', 'display_name': 'Daclatasvir', 'level': 5, 'score': 0.99917006}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.87023985}, {'id': 'https://openalex.org/C2780040827', 'wikidata': 'https://www.wikidata.org/wiki/Q421862', 'display_name': 'Ribavirin', 'level': 4, 'score': 0.5825915}, {'id': 'https://openalex.org/C2776408679', 'wikidata': 'https://www.wikidata.org/wiki/Q708693', 'display_name': 'Hepatitis C virus', 'level': 3, 'score': 0.57146746}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.53851753}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5261597}, {'id': 'https://openalex.org/C2778390639', 'wikidata': 'https://www.wikidata.org/wiki/Q2502747', 'display_name': 'Sofosbuvir', 'level': 5, 'score': 0.43568558}, {'id': 'https://openalex.org/C132379496', 'wikidata': 'https://www.wikidata.org/wiki/Q83141645', 'display_name': 'NS3', 'level': 4, 'score': 0.4218223}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.33013812}, {'id': 'https://openalex.org/C2522874641', 'wikidata': 'https://www.wikidata.org/wiki/Q808', 'display_name': 'Virus', 'level': 2, 'score': 0.2726034}], 'mesh': [{'descriptor_ui': 'D019698', 'descriptor_name': 'Hepatitis C, Chronic', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D007093', 'descriptor_name': 'Imidazoles', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D007546', 'descriptor_name': 'Isoquinolines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D000998', 'descriptor_name': 'Antiviral Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002219', 'descriptor_name': 'Carbamates', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002986', 'descriptor_name': 'Clinical Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004347', 'descriptor_name': 'Drug Interactions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D024882', 'descriptor_name': 'Drug Resistance, Viral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004359', 'descriptor_name': 'Drug Therapy, Combination', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019698', 'descriptor_name': 'Hepatitis C, Chronic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007093', 'descriptor_name': 'Imidazoles', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D007093', 'descriptor_name': 'Imidazoles', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D007093', 'descriptor_name': 'Imidazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007546', 'descriptor_name': 'Isoquinolines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D007546', 'descriptor_name': 'Isoquinolines', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D007546', 'descriptor_name': 'Isoquinolines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011759', 'descriptor_name': 'Pyrrolidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D014633', 'descriptor_name': 'Valine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014633', 'descriptor_name': 'Valine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1358/dot.2015.51.11.2414528', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S202615048', 'display_name': 'Drugs of today', 'issn_l': '1699-3993', 'issn': ['1699-3993', '1699-4019'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4360969288', 'host_organization_name': 'Prous Science', 'host_organization_lineage': ['https://openalex.org/P4360969288'], 'host_organization_lineage_names': ['Prous Science'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/26744738', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.85, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4385898514', 'https://openalex.org/W4364376362', 'https://openalex.org/W4281902367', 'https://openalex.org/W3209102118', 'https://openalex.org/W3031498534', 'https://openalex.org/W2990662371', 'https://openalex.org/W2767376718', 'https://openalex.org/W2560876434', 'https://openalex.org/W2460376027', 'https://openalex.org/W2114705120'], 'abstract_inverted_index': {'Daclatasvir': [0, 129], 'is': [1, 14, 142], 'a': [2, 143], 'nonstructural': [3], 'protein': [4], '5A': [5], 'inhibitor': [6, 18], 'of': [7, 19, 24, 36, 49, 108, 120], 'hepatitis': [8], 'C': [9], 'virus': [10], '(HCV)': [11], 'replication.': [12, 21], 'Asunaprevir': [13], 'an': [15], 'NS3/4A': [16], 'complex': [17], 'HCV': [20, 40], 'The': [22, 118], 'combination': [23, 119], 'daclatasvir': [25, 121], 'and': [26, 53, 63, 110, 122, 130], 'asunaprevir': [27, 123, 131], 'has': [28], 'been': [29], 'approved': [30], 'in': [31, 54, 72, 78, 94, 103, 125], 'Japan': [32], 'for': [33, 134, 146], 'the': [34, 106, 115], 'treatment': [35, 116], 'genotype': [37, 57, 79, 86], '1': [38, 58], 'chronic': [39], 'infection.': [41], 'In': [42], 'vitro': [43], 'studies': [44, 66], 'have': [45, 67], 'documented': [46], 'potent': [47, 70], 'activity': [48, 71], 'these': [50, 104], 'drugs,': [51], 'individually': [52], 'combination,': [55], 'against': [56], 'HCV.': [59, 88], 'Results': [60], 'from': [61], 'completed': [62], 'ongoing': [64], 'clinical': [65], 'confirmed': [68], 'this': [69], 'patients,': [73], 'with': [74, 85], 'better': [75, 93], 'responses': [76], 'noted': [77], '1b': [80], 'patients': [81, 84, 96], 'compared': [82, 97], 'to': [83, 98, 113], '1a': [87], 'Response': [89], 'rates': [90], 'are': [91, 101, 132], 'also': [92], 'treatment-naive': [95], 'those': [99], 'who': [100], 'treatment-experienced;': [102], 'cases,': [105], 'addition': [107], 'interferon': [109], 'ribavirin': [111], 'appears': [112], 'enhance': [114], 'response.': [117], 'is,': [124], 'general,': [126], 'well': [127], 'tolerated.': [128], 'substrates': [133], 'cytochrome': [135], 'P450': [136], '3A4': [137], 'enzymatic': [138], 'pathway;': [139], 'thus,': [140], 'there': [141], 'substantial': [144], 'potential': [145], 'drug': [147], 'interactions.': [148]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2414183052', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 2}, {'year': 2017, 'cited_by_count': 1}], 'updated_date': '2025-01-04T19:23:24.351140', 'created_date': '2016-06-24'}